On Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride ...

The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg: Our Bureau, Mumbai Monday, November 17, 2025, 13:30 Hrs [IST] Alembic ...

Indian drugmaker Alembic Pharmaceuticals posted a 20.4% rise in second-quarter profit on Tuesday, aided by strong demand for ...

Real-time updates on ALEMBIC PHARMA share price. Check out the detailed analysis of the company in this live blog.

Alembic Pharmaceuticals' shares are expected to draw attention following the USFDA's approval of its key hypertension drug, Diltiazem Hydrochloride Tablets.

Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.

Alembic Pharmaceuticals reported a strong second quarter with profit rising 21% year-on-year to ₹185 crore, supported by ...

Vadodara: Alembic Pharma has announced that the Company's Branch office in the United Arab Emirates has been converted into a ...

Research from the NIH indicates that hibiscus tea may help prevent or manage diabetes and related health issues. Made from ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug ...